HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazumitsu Sugiura Selected Research

Impetigo (Impetigo Contagiosa)

3/2022Recurrence of impetigo herpetiformis carrying compound heterozygous mutations in IL36RN after remission with secukinumab.
1/2022Impetigo herpetiformis successfully treated with brodalumab.
2/2021Efficacy and safety of treatment with anti-tumor necrosis factor-α drugs for severe impetigo herpetiformis.
3/2019An effective and promising treatment with adalimumab for impetigo herpetiformis with postpartum flare-up.
6/2018Impetigo herpetiformis with IL-36RN mutation successfully treated with secukinumab.
5/2018Autoinflammatory keratinization diseases: An emerging concept encompassing various inflammatory keratinization disorders of the skin.
10/2017Impetigo Herpetiformis Complicated with Intrauterine Growth Restriction Treated Successfully with Granulocyte and Monocyte Apheresis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazumitsu Sugiura Research Topics

Disease

17Psoriasis (Pustulosis Palmaris et Plantaris)
11/2022 - 09/2009
12Dermatomyositis (Dermatopolymyositis)
09/2015 - 09/2010
9Myositis (Idiopathic Inflammatory Myopathies)
12/2016 - 09/2010
8Melanoma (Melanoma, Malignant)
08/2021 - 09/2010
7Impetigo (Impetigo Contagiosa)
03/2022 - 10/2017
7Neoplasms (Cancer)
01/2021 - 08/2010
6Autoimmune Diseases (Autoimmune Disease)
03/2015 - 11/2004
5Ichthyosis (Xeroderma)
11/2017 - 05/2014
4Systemic Scleroderma (Systemic Sclerosis)
03/2015 - 04/2009
4Polymyositis
03/2015 - 06/2013
4Interstitial Lung Diseases (Interstitial Lung Disease)
04/2014 - 01/2011
3Acute Generalized Exanthematous Pustulosis
04/2021 - 03/2015
3Pemphigus (Pemphigus Vulgaris)
10/2020 - 01/2013
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2013 - 09/2009
3Atopic Dermatitis (Atopic Eczema)
09/2011 - 11/2004
2Onychomycosis (Tinea Unguium)
10/2021 - 08/2019
2Brain Neoplasms (Brain Tumor)
08/2021 - 04/2004
2Drug Eruptions (Drug Eruption)
02/2021 - 05/2012
2Pain (Aches)
01/2021 - 12/2016
2Erythema
07/2020 - 08/2014
2Wounds and Injuries (Trauma)
01/2020 - 04/2004
2Rheumatoid Arthritis
06/2017 - 07/2014
2Ulcer
12/2016 - 04/2009
2Alopecia (Baldness)
12/2016 - 11/2004
2Inflammation (Inflammations)
12/2016 - 08/2013
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2015 - 01/2005
2Amyopathic dermatomyositis
08/2014 - 01/2011
2Idiopathic Pulmonary Fibrosis
06/2014 - 02/2014
2Connective Tissue Diseases (Connective Tissue Disease)
04/2014 - 02/2006
2Lamellar Ichthyosis (Harlequin Ichthyosis)
11/2013 - 03/2013
1Neoplasm Metastasis (Metastasis)
08/2021
1Urticaria (Hives)
07/2021
1Basal Cell Carcinoma (Rodent Ulcer)
03/2021
1Hepatitis
01/2021
1Hemorrhage
01/2021
1Autistic Disorder (Autism)
01/2021
1Hypotrichosis
10/2020
1Bronchiolitis Obliterans
10/2020
1Hypothyroidism
07/2020
1Ovarian Neoplasms (Ovarian Cancer)
07/2020

Drug/Important Bio-Agent (IBA)

25AutoantibodiesIBA
12/2016 - 04/2004
15AntibodiesIBA
04/2015 - 04/2004
8Proteins (Proteins, Gene)FDA Link
05/2018 - 01/2007
7EnzymesIBA
11/2017 - 04/2004
6Messenger RNA (mRNA)IBA
10/2022 - 03/2013
6lens epithelium-derived growth factorIBA
01/2013 - 11/2004
4CytokinesIBA
11/2020 - 03/2014
3InterleukinsIBA
02/2022 - 01/2017
3Nonsense Codon (Nonsense Mutation)IBA
10/2017 - 05/2014
3Amoxicillin (Wymox)FDA LinkGeneric
03/2015 - 02/2014
3AutoantigensIBA
01/2013 - 01/2007
2secukinumabIBA
03/2022 - 06/2018
2efinaconazoleIBA
10/2021 - 08/2019
2SolutionsIBA
10/2021 - 08/2019
2LigandsIBA
08/2021 - 01/2019
2ErbB Receptors (EGF Receptor)IBA
08/2021 - 08/2010
2IpilimumabIBA
08/2021 - 01/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2021 - 03/2014
2DNA (Deoxyribonucleic Acid)IBA
11/2020 - 01/2019
2Mi-2 antibodiesIBA
12/2016 - 08/2012
2transcriptional intermediary factor 1IBA
12/2016 - 08/2012
2Immunoglobulin A (IgA)IBA
11/2016 - 04/2015
2UbiquitinIBA
09/2015 - 06/2013
2Endoplasmic Reticulum Chaperone BiPIBA
09/2011 - 09/2009
2Immunoglobulin G (IgG)IBA
09/2011 - 11/2004
1BNT162 VaccineIBA
10/2022
1COVID-19 VaccinesIBA
10/2022
1brodalumabIBA
01/2022
1NivolumabIBA
08/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2021
1ErythropoietinFDA Link
08/2021
1dabrafenibIBA
08/2021
1trametinibIBA
08/2021
1CosmeticsIBA
07/2021
1Acetaminophen (Paracetamol)FDA LinkGeneric
04/2021
1Cisplatin (Platino)FDA LinkGeneric
03/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2021
1fosravuconazole L-lysine ethanolateIBA
02/2021
1Janus Kinase 1IBA
01/2021
1PowdersIBA
01/2021
1Zinc OxideFDA Link
01/2021
1Mohs' pasteIBA
01/2021
1Starch (Cornstarch)IBA
01/2021
1N- alpha- benzoyl- N5- (2- chloro- 1- iminoethyl)- L- ornithine amideIBA
11/2020
1arginine deiminaseIBA
11/2020
1Imiquimod (Aldara)FDA LinkGeneric
11/2020
1ChemokinesIBA
11/2020
1Minoxidil (Rogaine)FDA LinkGeneric
10/2020
1Rituximab (Mabthera)FDA Link
10/2020
1Immunoglobulins (Immunoglobulin)IBA
10/2020
1Immune Checkpoint InhibitorsIBA
07/2020
1ThyroglobulinFDA Link
07/2020
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
07/2020
1Programmed Cell Death 1 ReceptorIBA
07/2020
1ZincIBA
07/2020

Therapy/Procedure

6Therapeutics
08/2021 - 10/2013
2Blood Component Removal (Apheresis)
11/2022 - 10/2017
1Drug Therapy (Chemotherapy)
08/2021
1Combination Drug Therapy (Combination Chemotherapy)
03/2021
1Palliative Care (Palliative Therapy)
01/2021